ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 117 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $26,559,000 | +1.5% | 650,000 | 0.0% | 0.52% | -8.1% |
| Q1 2021 | $26,169,000 | -30.3% | 650,000 | +2.4% | 0.57% | -28.3% |
| Q4 2020 | $37,548,000 | +21.6% | 635,000 | 0.0% | 0.80% | +1.5% |
| Q3 2020 | $30,880,000 | +11.0% | 635,000 | +10.4% | 0.78% | +2.8% |
| Q2 2020 | $27,819,000 | +83.7% | 575,000 | +5.5% | 0.76% | +21.9% |
| Q1 2020 | $15,140,000 | -7.2% | 545,000 | 0.0% | 0.63% | +21.6% |
| Q4 2019 | $16,306,000 | -3.2% | 545,000 | 0.0% | 0.52% | -23.2% |
| Q3 2019 | $16,841,000 | -41.9% | 545,000 | -9.2% | 0.67% | -36.0% |
| Q2 2019 | $28,980,000 | – | 600,000 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |